By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioInvent 

Ideon Science and Technology Park
Sölvegatan 41
Lund    S-223 70  Sweden
Phone: 46-46-286-8550 Fax: 46-46-211-0806


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
BioInvent (BOVNF) Interim Report 1 January – 31 March 2016 4/26/2016 12:31:01 PM
Multiple Myeloma Phase II Study Of BioInvent (BOVNF)'s Antibody BI-505 Ready To Start 4/18/2016 11:24:50 AM
BioInvent (BOVNF)’s Rights Issue Completed 4/15/2016 9:59:03 AM
BioInvent (BOVNF): Annual Report 2015 3/23/2016 10:06:10 AM
Resolutions Of The Extraordinary General Meeting Of BioInvent (BOVNF) 3/18/2016 10:57:48 AM
BioInvent (BOVNF) Is Granted A Patent In Europe For The Immune-Oncology Antibody BI-505 3/16/2016 9:31:44 AM
BioInvent (BOVNF) And Oncurious Partner With US Research Consortium To Accelerate Phase I/IIa Trial Of TB-403 3/15/2016 9:13:59 AM
BioInvent (BOVNF) Receives €2 Million Milestone Payment From Daiichi Sankyo For Licensed N-CoDeR Antibody Progressing Into Phase I Clinical Trial 2/29/2016 11:39:42 AM
BioInvent (BOVNF) Financial Statement 1 January – 31 December 2015 2/17/2016 10:11:32 AM
BioInvent (BOVNF) Announces FDA Acceptance Of The Investigational New Drug Application For The Phase I/IIa Study With TB-403 1/7/2016 1:37:03 PM
12345678910...
//-->